SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040353
Filing Date
2019-11-05
Accepted
2019-11-05 16:02:30
Documents
66
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q torc-10q_20190930.htm 10-Q 1738769
2 EX-10.1 torc-ex101_12.htm EX-10.1 38620
3 EX-31.1 torc-ex311_6.htm EX-31.1 15649
4 EX-31.2 torc-ex312_7.htm EX-31.2 15743
5 EX-32.1 torc-ex321_9.htm EX-32.1 7797
  Complete submission text file 0001564590-19-040353.txt   6617979

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT torc-20190930.xml EX-101.INS 1498260
7 XBRL TAXONOMY EXTENSION SCHEMA torc-20190930.xsd EX-101.SCH 47572
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE torc-20190930_cal.xml EX-101.CAL 36488
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE torc-20190930_def.xml EX-101.DEF 172861
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE torc-20190930_lab.xml EX-101.LAB 378697
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE torc-20190930_pre.xml EX-101.PRE 306750
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 191193219
SIC: 2834 Pharmaceutical Preparations